- Home
- BRLT vs FEMY Comparison
BRLT vs FEMY Comparison
Compare BRLT & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- FEMY
- Stock Information
- Founded
- BRLT 2005
- FEMY 2004
- Country
- BRLT United States
- FEMY United States
- Employees
- BRLT N/A
- FEMY N/A
- Industry
- BRLT Consumer Specialties
- FEMY Medical/Dental Instruments
- Sector
- BRLT Consumer Discretionary
- FEMY Health Care
- Exchange
- BRLT Nasdaq
- FEMY Nasdaq
- Market Cap
- BRLT 19.8M
- FEMY 23.1M
- IPO Year
- BRLT 2021
- FEMY 2021
- Fundamental
- Price
- BRLT $2.11
- FEMY $0.57
- Analyst Decision
- BRLT Hold
- FEMY Strong Buy
- Analyst Count
- BRLT 2
- FEMY 3
- Target Price
- BRLT $1.80
- FEMY $7.33
- AVG Volume (30 Days)
- BRLT 3.3M
- FEMY 376.8K
- Earning Date
- BRLT 08-07-2025
- FEMY 08-08-2025
- Dividend Yield
- BRLT N/A
- FEMY N/A
- EPS Growth
- BRLT N/A
- FEMY N/A
- EPS
- BRLT N/A
- FEMY N/A
- Revenue
- BRLT $422,218,000.00
- FEMY $1,887,016.00
- Revenue This Year
- BRLT $3.79
- FEMY $283.83
- Revenue Next Year
- BRLT $3.85
- FEMY $161.03
- P/E Ratio
- BRLT N/A
- FEMY N/A
- Revenue Growth
- BRLT N/A
- FEMY 98.61
- 52 Week Low
- BRLT $1.25
- FEMY $0.55
- 52 Week High
- BRLT $2.73
- FEMY $1.80
- Technical
- Relative Strength Index (RSI)
- BRLT 61.28
- FEMY 26.21
- Support Level
- BRLT $2.08
- FEMY $0.72
- Resistance Level
- BRLT $2.37
- FEMY $0.72
- Average True Range (ATR)
- BRLT 0.26
- FEMY 0.07
- MACD
- BRLT 0.03
- FEMY -0.02
- Stochastic Oscillator
- BRLT 54.24
- FEMY 5.67
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.